Organisation
Hepatology
Division
The labo of Hepatology studies pathophysiology and treatment of liver and pancreas diseases and metabolism.
Projects
41 - 50 of 50
- Towards organization of care for patients with hereditary haemochromatosisFrom1 Jan 2012 → 28 Apr 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Exploring viral evolution with respect to disease progression and therapy-response in HCV infection.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
- Hepatocytic differentiation of hepatic progenitor cells in acute and chronic hepatocytic human liver diseases.From1 Nov 2010 → 15 Nov 2010Funding: BOF - Other initiatives
- The role of microcirculatory dysfunction, the innate immune system and intestinal permeability in the early onset of acute-on-chronic liver failure.From1 Oct 2010 → 30 Sep 2015Funding: FWO fellowships
- Role of progenitor cells in liver carcinogenesis: basis for a new prognostically relevant classification of liver cancer.From1 Jan 2010 → 31 Dec 2015Funding: FWO research project (including WEAVE projects)
- Modulation of parasympathetic nerve activity as a strategy for the treatment of the hyperdynamic circulation in portal hypertensionFrom1 Sep 2009 → 30 Jun 2010Funding: Own budget, for example: patrimony, inscription fees, gifts
- Optimalization of a biomodulation protocol to attenuate ichemia/reperfusion injury in view of expanding the amount of organs for transplantation.From1 Jan 2009 → 31 Dec 2012Funding: FWO research project
- Evaluation of molecular, dosimetric and ultrastructural imaging in the management of neuroendocrine tumors with Peptide Receptor Radionuclide Therapy: results of a prospective, monocentric, non-controlled phase II studyFrom1 Nov 2008 → 27 May 2015Funding: Nonprofit institution or equivalents
- Hypothermic machine perfusion of non heart beating donor livers: a preclinical porcine study.From1 Jan 2008 → 31 Dec 2013Funding: FWO research project
- Platelet activation as a disease modifier in chronic chloestatic liver disease.From1 Jan 2008 → 31 Dec 2011Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 1341
- OPTIMAL TIMING OF ENDOSCOPY IS ASSOCIATED WITH LOWER 42-DAY MORTALITY IN VARICEAL BLEEDING(2019)
Authors: Stig B Laursen, Adrian J Stanley, Virginia Hernandez-Gea, Bogdan Procopet, Alvaro Giraldez, Candido V Sanchez, Dominique Thabut, Luis Ibanez-Samaniego, Javier Martinez, Joan Genesca, et al.
Pages: AB95 - AB95 - LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS: RESPONDER ANALYSIS OF OVER 5 YEARS OF TREATMENT IN THE POISE TRIAL(2020)
Authors: Bettina E Hansen, David Jones, Marco Carbone, Christopher L Bowlus, Frederik Nevens, Andreas E Kremer, Alexander Liberman, Leigh MacConell, Gideon M Hirschfield
Pages: 752A - 752A - Optimal timing of endoscopy is associated with lower 42-day mortality in variceal bleeding(2019)
Authors: Stig Borbjerg Laursen, Adrian Stanley, Virginia Hernandez-Gea, Bogdan Procopet, Alvaro Giraldez, Lucio Amitrano, Candid Villanueva, Dominique Thabut, Luis Ibanez-Samaniego, Gilberto Silva-Junior, et al.
Pages: E16 - E17 - Elevated alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a multi-center pooled analysis on individual patient data(2014)
Authors: Tom J Gevers, Frederik Nevens, Vicente E Torres, Marie C Hogan, Joost Drenth
Pages: 431A - 431A - HIGH-THROUGHPUT SEQUENCING OF THE HUMAN HEPATIC PROGENITOR CELL NICHE REVEALS DIFFERENT SIGNALLING PATHWAYS DEPENDING ON THE UNDERLYING CHRONIC LIVER DISEASE(2015)
Authors: Olivier Govaere, Jasper Wouters, Wouter Van Delm, R van Eijsden, An Ceulemans, Werner Van Steenbergen, Diethard Monbaliu, Frederik Nevens, Tania Roskams
Pages: S239 - S239 - Increasing the Tolerance for Warm Ischemia of Liver Grafts from DCD Donors by the Leuven Drug Protocol(2011)
Authors: Jos van Pelt, Katrien Vekemans, Diethard Monbaliu, E Balligand, Veerle Heedfeld, Jacques Pirenne
Pages: 437 - 437 - Treatment of Hepatorenal syndrome(2009)
Authors: Frederik Nevens
Pages: 548 - 554 - Hepatitis C genotype 4 response rate to pegylated interferon and ribavirin treatment in Belgium is similar to genotype 1(2010)
Authors: Frederik Nevens
Pages: 229 - 234 - The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months.(2014)
Authors: P De Simone, GM Kaiser, L De Carlis, HJ Metselaar, C Duvoux, Frederik Nevens, L Fischer, J Fung, G Dong, B Rauer, et al.
Pages: S106 - S106 - EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL(2013)
Authors: F Saliba, HJ Metselaar, S Beckebaum, C Duvoux, M Navasa, G Dong, P Lopez, Frederik Nevens
Pages: S79 - S80